pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
the cabinet

Drugs

8,127 products tracked · 1,561 matching

★ save view↓export CSV
phase
allMarketedPhase 3Phase 2Phase 1Preclinical
sort
catalystsrecentname
therapeutic area
allOncology1831Infectious Disease718Cardiology425Pulmonology396Immunology371Ophthalmology368Dermatology300Women's Health
viewlistcards
  • Phase 2
    NC-410
    Cervical Cancer$NXTC NextCure, Inc.
  • Phase 2
    NCS-01
    Acute Ischemic Stroke NC Medical Research Inc
  • Phase 2
    ND-10 ER
    Myopia Theialife Sciences Pvt Ltd
  • Phase 2
← prev
page 20 of 53
next →
131
Pain89
Neurology1
NEO-100
Recurrent Glioblastoma Multiforme (GBM)
$NTHI NEONC TECHNOLOGIES HOLDINGS, INC.
  • Phase 2
    NEO-212
    Astrocytoma$NTHI NEONC TECHNOLOGIES HOLDINGS, INC.
  • Phase 2
    NG-350A
    Epithelial Tumor Akamis Bio Ltd
  • Phase 2
    NGGT-002
    Phenylketonuria (PKU) Next Generation Gene Therapeutics Inc
  • Phase 2
    NMDP-02
    ignaseclant
    Spinal Muscular Atrophy (SMA) NMD Pharma AS
  • Phase 2
    NMDP-08
    ignaseclant
    Charcot-Marie-Tooth Disease Type I NMD Pharma AS
  • Phase 2
    NOUS-209
    Gastric Cancer Nouscom AG
  • Phase 2
    NP-213
    Novexatin
    Onychomycosis (Tinea Unguium) Novabiotics Ltd
  • Phase 2
    NRT-023
    Post Partum Depression (Maternal Depression / Postnatal D… Nanjing Noratech Pharmaceutical Inc
  • Phase 2
    NS-050
    Duchenne Muscular Dystrophy NS Pharma Inc
  • Phase 2
    NS-229
    Eosinophilic Granulomatosis with Polyangiitis (Churg-Stra… Nippon Shinyaku Co Ltd
  • Phase 2
    NT-101
    Wet (Neovascular / Exudative) Macular Degeneration NexThera Co Ltd
  • Phase 2
    NT-219
    Metastatic Colorectal Cancer$PPBT PURPLE BIOTECH LTD.
  • Phase 2
    NTCDM-3
    Clostridioides difficile Infections (Clostridium difficil… Destiny Pharma Ltd
  • Phase 2
    NTM-006
    Post-Operative Pain Neumentum Inc
  • Phase 2
    NTX-1472
    Social Anxiety Disorder (SAD/Social Phobia) Newleos Therapeutics Inc
  • Phase 2
    NTX-301
    Chronic Myelomonocytic Leukemia (CMML) Pinotbio Inc
  • Phase 2
    NVG-291
    Chronic Spinal Cord Injury$NGEN NERVGEN PHARMA CORP.
  • Phase 2
    NVX-108
    perflenapent
    Glioblastoma Multiforme (GBM) NuvOx Pharma LLC
  • Phase 2
    NVX-208
    perflenapent
    Acute Ischemic Stroke NuvOx Pharma LLC
  • Phase 2
    NX-210c
    Amyotrophic Lateral Sclerosis Axoltis Pharma SAS
  • Phase 2
    NanoDOX
    NanoDOX
    Wounds Resilience Government Services Inc
  • Phase 2
    Nerofe
    Nerofe
    Refractory Acute Myeloid Leukemia Immune System Key Ltd
  • Phase 2
    Norovirus [strains Norwalk GI.1 + Sydney GII.4] (bivalent) vaccine
    Norovirus Infections$VXRT Vaxart, Inc.
  • Phase 2
    NouvNeu-001
    Parkinson's Disease iRegene Therapeutics Co Ltd
  • Phase 2
    Nov-DB2
    Obesity NovMetaPharma Co Ltd
  • Phase 2
    NovOB
    Obesity NovMetaPharma Co Ltd